Buyers widening their own doors: demand already secured, far-side receiving constraint now being cleared
The model's full reasoning — Q2 2017 call → NO我们根据提供的财报电话会议记录,判断管理层是否传达了以下情况:公司已经拥有确定的需求或业务,但交付量受限于接收方的吸收能力,且接收方正在努力准备,相关业务大多尚未反映在已报告的结果中。 分析关键点: 1. 需求已确定:管理层提到多个产品线有设计胜利、正在出货、客户已下单等。例如,DOCSIS 3.1开始出货给美国主要运营商,MOCA 2.5开始出货,G.hn在亚洲电信运营商开始爬坡,微波回程RF收发器开始出货等。这些表明需求已存在。 2. 约束在接收方:管理层是否提到接收方(如客户、运营商)的自身准备(如安装、部署、认证等)是瓶颈?在记录中,管理层提到“ramp”和“deployment”等,但未明确说接收方能力不足。例如,关于DOCSIS 3.1,管理层说“ramps are always spotter a bit before they take off”,但未说客户无法接收。关于卫星,提到“lumpiness”和“concentrated operators”,但未说接收方准备。关于光学,提到“lack of bookings”和“market has not recovered”,这更像是需求不足而非接收方约束。关于G.hn,提到“initial ramp”和“strong and growing engagements”,但未明确说接收方准备。 3. 接收方正在清除约束:管理层是否描述接收方正在建设、认证等?记录中未明确提到。例如,关于MOCA,提到“operators are interested in utilizing”,但未说他们正在准备。关于G.hn,提到“design win”和“ramp to revenues in the second half of 2018”,但未说接收方正在准备。 总体来看,管理层主要谈论的是需求波动、市场疲软(如光学)、季节性(如电缆)和遗留产品下降,而不是接收方能力约束。没有明确描述接收方正在准备以吸收更多业务。因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
MKC · Q2 2018 → YESThe question is about whether management conveys that they already have secured business or demand, but the bottleneck is the counterparties' ability to receive, install, etc., and those counterpartie...**NO** The transcript describes a situation where McCormick has already won shelf-space changes and distribution improvements from retailers (customers have accepted the recommendations), but implementation is delayed due to retailers' own operational reset windows and competitor product sell-through. This is framed as a temporary, ongoing industry practice rather than a binding constraint being actively cleared right now to unlock a meaningfully larger volume of already-secured business. Management presents it as part of their category-management progress with runway ahead, not as counterparties clearing a receiving-side bottleneck that is already underway and will drive the bulk of the upside.
BIIB · Q2 2017 → YESThe question is about whether management conveys that they already have secured demand, but the bottleneck is the counterparties' ability to receive/install/etc., and those counterparties are already ...YES The transcript shows management conveying exactly this situation for SPINRAZA. Demand is already secured and arriving: “significant uptake in the U.S.” with “strong demand across patient types” and “roughly two third of patients treated to date having Type 2 or Type 3 SMA.” The binding constraint is on 60% of Type 2 patients who have had spinal surgery, creating intrathecal administration challenges on the receiving side.
BXP · Q1 2022 → YESThe question is about whether management conveys that they already have secured business or demand, but the bottleneck is the counterparties' ability to receive/install/etc., and those counterparties ...YES The transcript shows management conveying secured demand through signed leases totaling over 975,000 square feet on vacant space that have not yet commenced occupancy, plus an additional 1.3 million square feet in active negotiations and over 750,000 square feet in the development pipeline.